Serotonin transporter expression in rat brain regions and blood platelets: Aging and glucocorticoid effects

Biological Psychiatry

Volumn 41, Issue 2, 1997, Pages 172-183

  Slotkin, T A ^a   McCook, E C ^a   Ritchie, J C ^b   Carroll, B J ^a   Seidler, F J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b EMORY CLINIC   (United States)

Author keywords

aging; brain synaptosomes; dexamethasone; glucocorticoids; imipramine; paroxetine; plate lets

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; IMIPRAMINE; SEROTONIN;

AGING; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DEPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE; TRANSPORT KINETICS;

AGING; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BLOOD PLATELETS; BRAIN MAPPING; CARRIER PROTEINS; CEREBRAL CORTEX; DEXAMETHASONE; GLUCOCORTICOIDS; HIPPOCAMPUS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMIPRAMINE; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; PAROXETINE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTOSOMES;

EID: 0031040838     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00215-6     Document Type: Article

References (81)

1. Aghajanian GK, Charney DS, Duman RS, Heninger GR (1993): Neurobiology of Affective Disorders. New York: Raven Press.
2. 3H]-paroxetine binding in rat brain: Effect of imipramine and tetrahydroacridine. Life Sci 52:1767-1775.
3. 3H]imipramine binding in rat blood platelets and brain. Eur J Pharmacol 123:415-419.
4. Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J (1993): Effect of aging in human cortical pre-and postsynaptic serotonin binding sites. Brain Res 620:163-166.
5. Branconnier RJ, Oxenkrug GF, McIntyre I, Pomara N, Harto NE, Gershon S (1984): Prediction of serum cortisol response to dexamethasone in normal volunteers: A multivariate approach. Psychopharmacology 84:274-275.
6. Briley MS, Langer SZ, Raisman R, Sechter D, Zarifian E (1980): Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science 209:303-305.
7. Brodaty H, Peters K, Boyce P, Hickie I, Parker G, Mitchell P, Wilhelm K (1991): Age and depression. J Affect Disord 23:137-149.
8. 3H]imipramine binding sites in rat cerebral cortex. Eur J Pharmacol 110:393-394.
9. Carroll BJ, Curtis GC, Mendels J (1976): Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol Med 6:235-244.
10. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z, Lohr N, Steiner M, deVigne JP, Young E (1981): A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry 38:15-22.
11. Carroll BJ, Heath B, Jarrett DB (1975): Corticosteroids in brain tissue. Endocrinology 97:290-300.
12. Chan MY, Lee PHK (1985): Serotonin uptake and imipramine binding in rat platelets after chronic dexamethasone and amitriptyline treatment. Pharmacol Res Comm 17:619-632.
13. 3H]paroxetine to platelets of depressed patients: seasonal differences and effects of diagnostic classification. J Affect Disord 32:27-35.
14. Danish University Antidepressant Group (DUAG) (1986): Citalopram: clinical effect profile in comparison with clomipramine: A controlled multicenter study. Psycopharmacology (Berl) 90:131-138.
15. Danish University Antidepressant Group (DUAG) (1990): Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 18:289-299.
16. Davidoff MS, Lolova IS (1991): Age-related changes in serotonin-immunoreactivity in the telencephalon and diencephalon of rats. J Hirnforsch 32:745-753.
17. De Kloet ER (1991): Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 12:95-164.
18. Ebel A, Strosser MT, Kempf E (1987): Genotypic differences in central neurotransmitter responses to aging in mice. Neurobiol Aging 8:417-427.
19. Fumagalli F, Jones SR, Caron MG, Seidler FJ, Slotkin TA (1996): Expression of mRNA coding for the serotonin transporter in aged vs. young rat brain: Differential effects of glucocorticoids. Brain Res (in press).
20. Fuxe K, Cintra A, Chadi G, Gustafsson JÅ, Agnati LF (1994): Central glucocorticoid receptors and neuronal plasticity. Meth Neurosci 22:372-382.
21. Goudsmit E, Feenstra MG, Swaab DF (1990): Central monoamine metabolism in the male Brown-Norway rat in relation to aging and testosterone. Brain Res Bull 25:755-763.
22. Gozlan H, Daval G, Verge D, Spampinato U, Fattaccini CM, Gallissot MC, el Mestikawy S, Hamon M (1990): Aging associated changes in serotoninergic and dopaminergic pre-and postsynaptic neurochemical markers in the rat brain. Neurobiol Aging 11:437-449.
23. 3H]paroxetine binding to rat cortical membranes. Eur J Pharmacol 118:107-114.
24. Healy D, Leonard BE (1987): Monoamine transport in depression: kinetics and dynamics. J Affect Disord 12:91-103.
25. 3H]imipramine binding in intact human platelets. Biol Psychiatry 25:576-584.
26. 3H]paroxetine binding on human platelets. Biol Psychiatry 36:281-291.
27. Jesberger JA, Richardson JS (1985): Animal models of depression: Parallels and correlates to severe depression in humans. Biol Psychiatry 20:764-784.
28. Joëls M, De Kloet ER (1991): Effect of corticosteroid hormones on electrical activity in rat hippocampus. J Steroid Biochem Mol Biol 40:83-86.
29. 3H]-5-hydroxytryptamine uptake systems in rat brain regions. Brit J Pharmacol 67:387-391.
30. Kitayama I, Janson AM, Cintra A, Fuxe K, Agnati LF, Ogran S-O, Harfstrand A, Eneroth P, Gustafsson J-A (1988): Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. J Neural Transm 73:191-203.
31. Koenig JI, Gudelsky GA, Meltzer HY (1987): Stimulation of corticosterone and β-endorphin secretion in the rat by selective 5HT receptor subtype activation. Eur J Pharmacol 137:1-8.
32. Korte SM, Van Duin S, Bouws GAH, Koolhaas JM, Bohus B (1991): Involvement of hypothalamic serotonin in activation of the sympathoadrenalmedullary system and hypothalamopituitary-adrenocortical axis in male Wistar rats. Eur J Pharmacol 197:225-228.
33. 3H]Hemi-cholinium-3 binding sites in postmortem brains of human patients with Alzheimer's Disease and multi-infarct dementia. Exp Gerontol 30:125-136.
34. 3H]paroxetine. Psychopharmacology 110:235-239.
35. 1A receptor responsivity in unipolar depression. Biol Psychiatry 28:620-628.
36. Lorens SA, Hata N, Handa RJ, Van de Kar LD, Guschwan M, Goral J, Lee JM, Hamilton ME, Bethea CL, Clancy J (1990): Neurochemical, endocrine and immunological responses to stress in young and old Fischer 344 male rats. Neurobiol Aging 11:139-150.
37. Lupien S, Lecours AR, Schwartz G, Sharma S, Hauger RL, Meaney MJ, Nair NPV (1996): Longitudinal study of basal cortisol levels in healthy elderly subjects: Evidence for subgroups. Neurobiol Aging 17:95-105.
38. Machado A, Cano J, Santiago M (1986): The change with age in biogenic amines and their metabolites in the striatum of the rat. Arch Gerontol Geriatr 5:333-342.
39. Macs M, D'Hondt P, Martin M, Claes M, Schotte C, Vandewoude M, Blockx P (1991): L-5-Hydroxytryptophan stimulated cortisol escape from dexamethasone suppression in melancholic patients. Acta Psychiatr Scand 83:302-306.
40. Masoro EJ (1995): Glucocorticoids and aging. Aging Clin Exp Res 7:407-413.
41. Maupin B (1969): Blood Platelets in Man and Animals, vol. 1. Oxford: Pergamon Press.
42. McEwen BS (1992): Re-examination of the glucocorticoid hypothesis of stress and aging. Prog Brain Res 93:365-380.
43. Meaney MJ, O'Donnell D, Rowe W, Tannenbaum B, Steverman A, Walker M, Nair NPV, Lupien S (1995): Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging. Exp Gerontol 30:229-251.
44. Meister B, Johnson H, Ulfhake B (1995): Increased expression of serotonin transporter messenger RNA in raphe neurons of the aged rat. Mol Brain Res 33:87-96.
45. Meltzer HV, Lowy MT (1987): The serotonin hypothesis of depression. In Meltzer HV (eds), Psychopharmacology: The Third Generation of Progress. New York: Raven Press, pp 513-526.
46. 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotonergic innervation in the rat. Psychiatry Res 38:97-104.
47. Nelson JC, Mazure CM, Jatlow PI (1995): Desipramine treatment of major depression in patients over 75 years of age. J Clin Psychopharmacol 15:99-105.
48. Nemeroff CB, Bissette G, Slotkin TA, Seidler FJ, Miller BE, Ghanbari H (1991): Recent advances in the neurochemical pathology of Alzheimer's Disease: Studies of neuropeptides, cholinergic function and Alzheimer's Disease-associated protein. Ann N Y Acad Sci 640:193-196.
49. Nemeroff CB, Knight DL, Franks J, Craighead WE, Krishnan KRK (1994): Further studies on platelet serotonin transporter binding in depression. Am J Psychiatry 151:1623-1625.
50. Nemeroff CB, Knight DL, Krishnan KRR, Slotkin TA, Bissette G, Melville ML, Blazer DG (1988): Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression. Arch Gen Psychiatry 45:919-923.
51. Owens MJ, Nemeroff CB (1994): Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clin Chem 40:288-295.
52. Oxenkrug GF, McIntyre IM, Stanley M, Gershon S (1984): Dexamethasone suppression test: Experimental model in rats and effect of age. Biol Psychiatry 19:413-416.
53. Pascual J, Fontán A, Zarranz JJ, Berciano J, Flórez J, Pazos A (1991): High-affinity choline uptake carrier in Alzheimer's Disease: Implications for the cholinergic hypothesis of dementia. Brain Res 552:170-174.
54. Pepin MC, Govindan MV, Barden N (1992): Increased glucocorticoid receptor gene promoter activity after antidepressant treatment. Mol Pharmacol 41:1016-1022.
55. Pfohl B, Sherman B, Schlechte J, Stone R (1985): Pituitary-adrenal axis rhythm disturbances in psychiatric depression. Arch Gen Psychiatry 42:897-903.
56. Pletscher A (1988): Platelets as models: Use and limitations. Experientia 44:152-155.
57. Ritchie JC, Owens MJ, Mayer H, Watson JT, Kilts C, Carroll BJ (1992): Preliminary studies of 6-β-hydroxydexamethasone and its importance in the DST. Biol Psychiatry 32:825-833.
58. Ritchie JC, Scotch RL, Nemeroff CB, Carroll BJ (1990): The effect of age on DST status and plasma dexamethasone concentration in depressed patients. Biol Psychiatry 27:45A-46A.
59. Roose SP, Glassman AH, Attia E, Woodring S (1994): Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 151:1735-1739.
60. Schneider LS (1993): Efficacy of treatment for geropsychiatric patients with severe mental illness. Psychopharmacol Bull 29:501-524.
61. 3H]imipramine binding in aged human brain. J Neurochem 45:1382-1389.
62. Sharma RP, Pandey GN, Janicak PG, Peterson J, Comaty JE, Davis JM 1988): The effect of diagnosis and age on the DST: A meta-analytic approach. Biol Psychiatry 24:555-568.
63. Shimoda K, Yamada N, Ohi K, Tsujimoto T, Takahashi K, Takahashi S (1988): Chronic administration of tricyclic antidepressants suppresses hypothalamo-pituitary-adrenocortical activity in male rats. Psychoneuroendocrinology 13:431-440.
64. Slotkin TA, McCook EC, Nemeroff CB, Seidler FJ (1991): Species differences in α2-adrenergic regulation of platelet adenylate cyclase. Res Comm Chem Pathol Pharmacol 72: 259-271.
65. Slotkin TA, McCook EC, Ritchie JC, Seidler FJ (1995): Do glucocorticoids contribute to the abnormalities in serotonin transporter expression and function seen in depression? An animal model. Biol Psychiatry (in press).
66. Slotkin TA, Nemeroff CB, Bissette G, Seidler FJ (1994): Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's Disease: Evidence from rapid autopsy studies. J Clin Invest 94:696-702.
67. Slotkin TA, Seidler FJ, Crain BJ, Bell JM, Bissette G, Nemeroff CB (1990): Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: Implications for etiology and therapy. Proc Natl Acad Sci USA 87:2452-2455.
68. Slotkin TA, Whitmore WL, Barnes GA, Krishnan KRR, Blazer DG, Knight DL, Nemeroff CB (1989): Reduced inhibitory effect of imipramine on radiolabeled serotonin uptake into platelets in geriatric depression. Biol Psychiatry 25:687-691.
69. Slotkin TA, Whitmore WL, Dew KL, Kilts CD (1986): Uptake of serotonin into rat platelets and synaptosomes: comparative structure-activity relationships, energetics and evaluation of the effects of acute and chronic nortriptyline administration. Brain Res Bull 17:67-73.
70. Smith DF (1986): The stereoselectivity of serotonin uptake in brain tissue and blood platelets: The topography of the serotonin uptake area. Neurosci Biobehav Rev 10:37-46.
71. Snedecor GW, Cochran WG (1967): Statistical Methods. Ames, Iowa: Iowa State University Press.
72. Stangl D, Pfohl B, Zimmerman M, Coryell W, Corenthal C (1986): The relationship between age and post-dexamethasone cortisol: A test of three hypotheses. J Affect Disord 11:185-197.
73. Stiles ML, Allen LV, Prince SJ, Holland JS (1994): Stability of dexamethasone sodium phosphate, diphenhydramine hydrochloride, lorazepam, and metoclopramide hydrochloride in portable infusion-pump reservoirs. Am J Hosp Pharm 51: 514-517.
74. Stokes PE, Maas JW, Davis JM, Koslow SH, Casper RC, Stoll PM (1987): Biogenic amine and metabolite levels in depressed patients with high versus normal hypothalamic-pituitary-adrenocortical activity. Am J Psychiatry 144:868-872.
75. van Luijtelaar MG, Steinbusch HW, Tonnaer JA (1988): Aberrant morphology of serotonergic fibers in the forebrain of the aged rat. Neurosci Lett 95:93-96.
76. Venero JL, de la Roza C, Machado A, Cano J (1993): Age-related changes on monoamine turnover in hippocampus of rats. Brain Res 631:89-96.
77. Venero JL, Machado A, Cano J (1990): Determination of levels of biogenic amines and their metabolites and both forms of monoamine oxidase in prefrontal cortex of aged rats. Mech Ageing Dev 56:253-263.
78. Volz HP, Moller HJ (1994): Antidepressant drug therapy in the elderly: A critical review of the controlled clinical trials conducted since 1980. Pharmacopsychiatry 27:93-100.
79. Wilcox CS, Cohn JB, Linden RD, Heiser JF, Lucas PB, Morgan DL, DeFrancisco D (1992): Predictors of placebo response: A retrospective analysis. Psychopharmacol Bull 28:157-162.
80. Yamaguchi T, Yamaguchi A (1991): Serotonergic ligand binding in aging brain of experimental animals. Neurochem Res 16:469-473.
81. Young AH (1994): Glucocorticoids, serotonin and mood. Brit J Psychiatry 165:271-272.